215600 — SillaJen Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapSucker Stock

Annual income statement for SillaJen, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	R2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	ARS/A	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	1,670	254	5,013	3,940	3,927
Cost of Revenue
Gross Profit	—	—	1,483	1,457	727
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	47,880	20,604	29,514	25,283	32,049
Operating Profit	-46,210	-20,350	-24,501	-21,344	-28,123
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-47,825	-22,124	-23,901	-20,181	-26,441
Provision for Income Taxes
Net Income After Taxes	-47,825	-15,305	-24,593	-20,369	-26,526
Net Income Before Extraordinary Items
Net Income	-47,825	-15,305	-24,593	-20,369	-26,526
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	-47,825	-15,305	-24,593	-20,369	-26,526
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-454	-165	-217	-180	-213
Dividends per Share